NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prcourse infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.
The NIAID Division of Intramural Research (DIR) has collaborated with the Cambodian Ministry of Health’s National Center for Parasitology, Entomology, and Malaria Control (CNM) in Phnom Penh, Cambodia since 2005. NIAID-funded extramural and intramural research collaboration in Cambodia includes research projects focused on HIV, dengue, vector research, tuberculosis, and other emerging infectious diseases.
Milestones in NIAID collaborations include:
- Developing vaccine targets and biomarkers for mosquito-borne diseases by understanding the human immune response to mosquito saliva, a known accelerant of disease.
- Using metagenomic sequencing platforms to discover other pathogens causing disease in the Mekong. such as flea-borne rickettsial bacteria, other mosquito-borne viruses like chikungunya, and respiratory pathogens like SARS-CoV-2.
- Clinical research studies on HIV/AIDS, including projects that investigate antiretroviral therapy use and treatment response, reduction of risk behavior, co-infection with TB, and micronutrients.
- Funding used to facilitate cooperation and convening workshops in the local, regional, international level.
Please feel free to contact us with any queries or questions you may have.